220 related articles for article (PubMed ID: 1655484)
21. In vitro and in vivo characterization of the NMDA receptor-linked strychnine-insensitive glycine site.
Peeters BW; Vanderheyden PM
Epilepsy Res; 1992 Jul; 12(2):157-62. PubMed ID: 1356759
[TBL] [Abstract][Full Text] [Related]
22. In vivo modulation of N-methyl-D-aspartate receptor-dependent long-term potentiation by the glycine modulatory site.
Thiels E; Weisz DJ; Berger TW
Neuroscience; 1992; 46(3):501-9. PubMed ID: 1347648
[TBL] [Abstract][Full Text] [Related]
23. Effect of 5-fluoroindole-2-carboxylic acid (an antagonist of the NMDA receptor-associated glycine site) on the anticonvulsive activity of conventional antiepileptic drugs.
Kamiński R; Przywara B; Gasior M; Kleinrok Z; Czuczwar SJ
J Neural Transm (Vienna); 1998; 105(2-3):133-46. PubMed ID: 9660092
[TBL] [Abstract][Full Text] [Related]
24. Competitive NMDA receptor antagonists enhance the antielectroshock activity of various antiepileptics.
Pietrasiewicz T; Czechowska G; Dziki M; Turski WA; Kleinrok Z; Czuczwar SJ
Eur J Pharmacol; 1993 Nov; 250(1):1-7. PubMed ID: 7907019
[TBL] [Abstract][Full Text] [Related]
25. Differential effects of glycine on the anticonvulsant activity of D-cycloserine and L-701,324 in mice.
Wlaź P; Poleszak E
Pharmacol Rep; 2011; 63(5):1231-4. PubMed ID: 22180366
[TBL] [Abstract][Full Text] [Related]
26. Isobolographic analysis of interactions between remacemide and conventional antiepileptic drugs in the mouse model of maximal electroshock.
Borowicz KK; Malek R; Luszczki JJ; Ratnaraj N; Patsalos PN; Czuczwar SJ
Epilepsy Behav; 2007 Aug; 11(1):6-12. PubMed ID: 17602881
[TBL] [Abstract][Full Text] [Related]
27. Glycine potentiates the anticonvulsant action of diazepam and phenobarbital in kindled amygdaloid seizures of rats.
Peterson SL
Neuropharmacology; 1986 Dec; 25(12):1359-63. PubMed ID: 3561714
[TBL] [Abstract][Full Text] [Related]
28. Infusion of NMDA antagonists into the nucleus reticularis pontis oralis inhibits the maximal electroshock seizure response.
Peterson SL
Brain Res; 1995 Dec; 702(1-2):101-9. PubMed ID: 8846064
[TBL] [Abstract][Full Text] [Related]
29. Acute and chronic treatment with mianserin differentially affects the anticonvulsant activity of conventional antiepileptic drugs in the mouse maximal electroshock model.
Borowicz KK; Banach M; Zarczuk R; Lukasik D; Luszczki JJ; Czuczwar SJ
Psychopharmacology (Berl); 2007 Dec; 195(2):167-74. PubMed ID: 17653694
[TBL] [Abstract][Full Text] [Related]
30. Kynurenic acid antagonises responses to NMDA via an action at the strychnine-insensitive glycine receptor.
Birch PJ; Grossman CJ; Hayes AG
Eur J Pharmacol; 1988 Sep; 154(1):85-7. PubMed ID: 2846328
[TBL] [Abstract][Full Text] [Related]
31. Mechanism of glycine protection in hypoxic injury: analogies with glycine receptor.
Heyman S; Spokes K; Rosen S; Epstein FH
Kidney Int; 1992 Jul; 42(1):41-5. PubMed ID: 1321929
[TBL] [Abstract][Full Text] [Related]
32. Comparison of anticonvulsant effect of pentobarbital and phenobarbital against seizures induced by maximal electroshock and picrotoxin in rats.
Mehta AK; Ticku MK
Pharmacol Biochem Behav; 1986 Nov; 25(5):1059-65. PubMed ID: 3024184
[TBL] [Abstract][Full Text] [Related]
33. Anticonvulsant activity of antagonists and partial agonists for the NMDA receptor-associated glycine site in the kindling model of epilepsy.
Rundfeldt C; Wlaź P; Löscher W
Brain Res; 1994 Aug; 653(1-2):125-30. PubMed ID: 7982045
[TBL] [Abstract][Full Text] [Related]
34. A glycine antagonist reduces ischemia-induced CA1 cell loss in vivo.
Wood ER; Bussey TJ; Phillips AG
Neurosci Lett; 1992 Sep; 145(1):10-4. PubMed ID: 1334240
[TBL] [Abstract][Full Text] [Related]
35. Antiepileptogenic action of 7-chlorokynurenic acid on amygdala kindling of rats.
Namba T; Morimoto K; Yamada N; Otsuki S
Pharmacol Biochem Behav; 1993 Oct; 46(2):275-81. PubMed ID: 8265681
[TBL] [Abstract][Full Text] [Related]
36. N-(anilinomethyl)-p-isopropoxyphenylsuccinimide potentiates the anticonvulsant action of phenobarbital and valproate in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Kocharov SL; Czuczwar SJ
Neurosci Res; 2009 Jul; 64(3):267-72. PubMed ID: 19447295
[TBL] [Abstract][Full Text] [Related]
37. Anticonvulsant activities of N-benzyloxycarbonylglycine after parenteral administration.
Lambert DM; Poupaert JH; Maloteaux JM; Dumont P
Neuroreport; 1994 Mar; 5(7):777-80. PubMed ID: 8018849
[TBL] [Abstract][Full Text] [Related]
38. Convulsive thresholds and severity and the anticonvulsant effect of phenobarbital and phenytoin in adult rats administered 6-hydroxydopamine or 5,7-dihydroxytryptamine during postnatal development.
Waller SB; Buterbaugh GG
Pharmacol Biochem Behav; 1985 Sep; 23(3):473-8. PubMed ID: 3931103
[TBL] [Abstract][Full Text] [Related]
39. Effect of 4-(4-bromophenyl)-5-(3-chlorophenyl)-2,4-dihydro-3H-1,2,4-triazole-3-thione on the anticonvulsant action of different classical antiepileptic drugs in the mouse maximal electroshock-induced seizure model.
Luszczki JJ; Plech T; Wujec M
Eur J Pharmacol; 2012 Sep; 690(1-3):99-106. PubMed ID: 22732650
[TBL] [Abstract][Full Text] [Related]
40. Anticonvulsant effects of the glycine/NMDA receptor ligands D-cycloserine and D-serine but not R-(+)-HA-966 in amygdala-kindled rats.
Löscher W; Wlaź P; Rundfeldt C; Baran H; Hönack D
Br J Pharmacol; 1994 May; 112(1):97-106. PubMed ID: 8032669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
